Assessing Patient Satisfaction Following Sodium Glucose Co-Transporter 2 Inhibitor Treatment for Type 1 Diabetes Mellitus: A Prospective Study in Japan

INTRODUCTION: In Japan, several sodium glucose co-transporter 2 (SGLT2) inhibitors have been used for type 1 diabetes mellitus as an adjuvant therapy to insulin therapy; however, there are no clinical reports regarding the satisfaction of its use. Therefore, we conducted a survey among patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishibashi, Ryoichi, Baba, Yusuke, Kakinuma, Kyoka, Takasaki, Atsushi, Hiraga, Chihiro, Harama, Tomomi, Yamamoto, Tetsuya, Nakamura, Susumu, Koshizaka, Masaya, Maezawa, Yoshiro, Uchida, Daigaku, Okajima, Fumitaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843726/
https://www.ncbi.nlm.nih.gov/pubmed/33237553
http://dx.doi.org/10.1007/s13300-020-00971-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843726/
https://www.ncbi.nlm.nih.gov/pubmed/33237553
http://dx.doi.org/10.1007/s13300-020-00971-2

Ejemplares similares